678 related articles for article (PubMed ID: 10388077)
1. The Cost of Biological Terrorism.
Coffey DS
Oncologist; 1997; 2(6):XI-XII. PubMed ID: 10388077
[TBL] [Abstract][Full Text] [Related]
2. Beware the Medical-Industrial Complex.
Stevens CW; Glatstein E
Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
[TBL] [Abstract][Full Text] [Related]
3. The Cure for Cancer: Not If but When.
Black KL
Oncologist; 1997; 2(5):IX-X. PubMed ID: 10388068
[TBL] [Abstract][Full Text] [Related]
4. Family pediatrics: report of the Task Force on the Family.
Schor EL;
Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
[TBL] [Abstract][Full Text] [Related]
5. Clinical Trials: A Congressional Focus of Need.
Coltman CA
Oncologist; 1997; 2(4):VII-VIII. PubMed ID: 10388059
[TBL] [Abstract][Full Text] [Related]
6. Touting prevention, Clinton budget seeks increases for family planning.
Wash Memo Alan Guttmacher Inst; 1994 Feb; (4):1-2. PubMed ID: 12345595
[TBL] [Abstract][Full Text] [Related]
7. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
8. Funding impact of the National Cancer Act and beyond.
Kalberer JT; Newell GR
Cancer Res; 1979 Oct; 39(10):4274-84. PubMed ID: 383282
[TBL] [Abstract][Full Text] [Related]
9. AIDS funding bills now before House-Senate conferees.
AIDS Policy Law; 1997 Oct; 12(18):14-5. PubMed ID: 11364725
[TBL] [Abstract][Full Text] [Related]
10. "Just Another Statistic".
Machtay M; Glatstein E
Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
[TBL] [Abstract][Full Text] [Related]
11. Veto -- or threat thereof -- prevails over majority as 102nd Congress adjourns.
Wash Memo Alan Guttmacher Inst; 1992 Oct; (15):2-4. PubMed ID: 12317790
[TBL] [Abstract][Full Text] [Related]
12. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
Sayeed SA
Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
[TBL] [Abstract][Full Text] [Related]
13. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
14. Impact of the National Cancer Act on grant support.
Kalberer JT
Cancer Res; 1975 Mar; 35(3):472-81. PubMed ID: 1090361
[TBL] [Abstract][Full Text] [Related]
15. Title X may get 10% funding increase despite cutbacks for deficit.
Kaeser L
Contracept Technol Update; 1994 Apr; 15(4):53-4. PubMed ID: 12318753
[TBL] [Abstract][Full Text] [Related]
16. Change in argonne national laboratory: a case study.
Mozley A
Science; 1971 Oct; 174(4004):30-8. PubMed ID: 17755685
[TBL] [Abstract][Full Text] [Related]
17. Closing Remarks.
Reed E
Oncologist; 1996; 1(4):276-277. PubMed ID: 10388002
[TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. Six Sigma: not for the faint of heart.
Benedetto AR
Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
[TBL] [Abstract][Full Text] [Related]
20. Back to the Future for Clinical Oncology.
Chabner BA
Oncologist; 1996; 1(1 & 2):I. PubMed ID: 10387977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
